LIG Audit Status
This page is public. The editing interface lives at /cgi-bin/audit.cgi and requires login. Full-text AI processing status is at /cgi-bin/fulltext-status.cgi; paper upload is at /cgi-bin/fulltext-upload.cgi.
Batch audit-20260421-labels-seed42 · created 2026-04-21 07:03 · seed 42
caucasian
25 reviewed / 25 total
0 pending
Confirmed caucasian 25 · Not caucasian on review 0
white
25 reviewed / 25 total
0 pending
Confirmed white 24 · Not white on review 1
european
10 reviewed / 25 total
15 pending
Confirmed european 10 · Not european on review 0
other
25 reviewed / 25 total
0 pending
Confirmed other 25 · Not other on review 0
none of these labels
0 reviewed / 100 total
100 pending
Confirmed none of these labels 0 · Uses tracked labels on review 0
["Genetic characterization of <scp>GSD</scp> I in Serbian population revealed unexpectedly high incidence of <scp>GSD</scp> Ib and 3 novel <i><scp>SLC37A4</scp></i> variants"]
Clinical Genetics · 2017 · article 72601531 · 10.1111/cge.13093
Review target: other. Review status: reviewed
Audit result: confirmed other · reviewer georgina · 2026-05-26 21:44
Classifier flags: other: Serbian population
<jats:p>Glycogen storage disease (<jats:styled-content style="fixed-case">GSD</jats:styled-content>) type I is inborn metabolic disease characterized by accumulation of glycogen in multiple organs. We analyzed 38 patients with clinical suspicion of <jats:styled-content style="fixed-case">GSD</jats:styled-content> I using Sanger and next‐generation sequencing (<jats:styled-content style="fixed-case">NGS</jats:styled-content>). We identified 28 <jats:styled-content style="fixed-case">GSD</jats:styled-content> Ib and 5 GSD Ia patients. In 5 patients, <jats:styled-content style="fixed-case">GSD III</jats:styled-content>, <jats:styled-content style="fixed-case">VI</jats:styled-content>, <jats:styled-content style="fixed-case">IX</jats:styled-content>, cholesteryl‐ester storage disease and Shwachman‐Diamond syndrome diagnoses were set using <jats:styled-content style="fixed-case">NGS</jats:styled-content>. Incidences for <jats:styled-content style="fixed-case">GSD</jats:styled-content> Ia and <jats:styled-content style="fixed-case">GSD</jats:styled-content> Ib were estimated at 1:172 746 and 1:60 461 live‐births, respectively. Two variants were identified in <jats:italic><jats:styled-content style="fixed-case">G6PC</jats:styled-content></jats:italic> gene: c.<jats:styled-content style="fixed-case">247C</jats:styled-content>>T (p.<jats:styled-content style="fixed-case">Arg83Cys</jats:styled-content>) and c.<jats:styled-content style="fixed-case">518T</jats:styled-content>>C (p.<jats:styled-content style="fixed-case">Leu173Pro</jats:styled-content>). In <jats:italic><jats:styled-content style="fixed-case">SLC37A4</jats:styled-content></jats:italic> gene, 6 variants were detected. Three previously reported variants c.<jats:styled-content style="fixed-case">81T</jats:styled-content>>A (p.<jats:styled-content style="fixed-case">Asn27Lys</jats:styled-content>), c.<jats:styled-content style="fixed-case">162C</jats:styled-content>>A (p.<jats:styled-content style="fixed-case">Ser54Arg</jats:styled-content>) and c.1042_1043delCT (p.<jats:styled-content style="fixed-case">Leu348Valfs</jats:styled-content>*53) accounted for 87% of all analyzed alleles. Computational, transcription studies and/or clinical presentation in patients confirmed pathogenic effect of 3 novel variants: c.<jats:styled-content style="fixed-case">248G</jats:styled-content>>A (p.<jats:styled-content style="fixed-case">Gly83Glu</jats:styled-content>), c.<jats:styled-content style="fixed-case">404G</jats:styled-content>>A (p.<jats:styled-content style="fixed-case">Gly135Asp</jats:styled-content>) and c.<jats:styled-content style="fixed-case">785G</jats:styled-content>>A (p.<jats:styled-content style="fixed-case">Ser263Glyfs</jats:styled-content>*33 or p.<jats:styled-content style="fixed-case">Gly262Asp</jats:styled-content>). In the cohort, hepatomegaly, hypoglycemia and failure to thrive were the most frequent presenting signs of <jats:styled-content style="fixed-case">GSD</jats:styled-content> Ia, while hepatomegaly and recurrent bacterial infections were clinical hallmarks of <jats:styled-content style="fixed-case">GSD</jats:styled-content> Ib. All <jats:styled-content style="fixed-case">GSD</jats:styled-content> Ib patients developed neutropenia while 20.6% developed inflammatory bowel disease. Our study revealed the highest worldwide incidence of <jats:styled-content style="fixed-case">GSD</jats:styled-content> Ib. Furthermore, description of 3 novel variants will facilitate medical genetic practice.</jats:p>